Lactogynal LP 2 vaginal tablets — Made in France — Free Delivery

Brand: Biosea
Product Code: Lactogynal LP
Availability: In Stock

$42.07

Description

Product description

Capsules vaginal transparent, gelatinous. The contents of the capsules are light yellow powder with a brownish tint.

Lactobacillus casei is a Gram-positive, rod-shaped, anaerobic, non-spore-forming bacterium. Lactobacillus casei is the normal obligate flora of the human oral cavity, intestines, vulva and vagina. Lactobacillus casei, along with other species of lactobacilli (including Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus cellobiosum), are present in the normal flora of a woman's vulva and vagina.

Colonization of the vagina with live rods Lactobacillus casei rhamnosus Doderleini creates a similar physiological environment in the vagina. The Lactobacillus casei rhamnosus Doderleini strain in the composition of the Lactoginal preparation has antagonistic activity against a wide range of pathogenic and opportunistic bacteria (including Staphylococcus spp., Proteus spp., enteropathogenic Escherichia coli), improves local metabolic processes and helps restore natural local immunity.

With the introduction of the capsule of the preparation Lactoginal into the vagina, the gelatin shell of the capsule dissolves with the release of a lyophilized culture of live lactobacilli.

It has been shown in vitro that Lactobacillus casei rhamnosus Doderleini, within a few hours after administration, leads to the necessary decrease in pH, contributing to the restoration of the natural microflora of the vagina.

Deficiency of lactobacilli is one of the important factors in the development of vulvovaginal candidiasis. Lactobacilli are physiological antagonists of yeast-like fungi of the genus Candida due to the secretion of antifungal substances and competition for receptors on vaginal epitheliocytes (suppress the attachment of Candida fungi to vaginal epitheliocytes, inhibit their growth and reproduction).

The results of a clinical study showed the effectiveness of Lactoginal in restoring the normal microflora of the vagina and preventing recurrent vulvovaginal candidiasis when used after completion of antifungal therapy.

Compound

Magnesium stearate - 3.41 mg

Lactose monohydrate - 5.59 mg.

Potato starch (~41% by weight of the lyophilisate).

Lactose monohydrate (~20.6% by weight of the lyophilisate).

Sodium glutamate (~4.5% by weight of the lyophilizate).

Sodium thiosulfate (~26.8% by weight of the lyophilisate).

Gelatin.

Indications

Restoration of the normal microflora of the vagina after antibiotic therapy for bacterial vaginosis.

Prevention of recurrence of vulvovaginal candidiasis (including exacerbations of recurrent vulvovaginal candidiasis) after local and / or systemic antifungal therapy.

In preparation for planned gynecological operations.

In prenatal preparation of pregnant women who are at risk for bacterial vaginosis.

Dosing regimen

The preparation is used intravaginally. The capsule should be inserted into the vagina, moistened with a small amount of water to accelerate the dissolution of the preparation.

To restore the normal microflora of the vagina after antibiotic therapy for bacterial vaginosis, 1 caps is used. morning and evening for 7 days or 1 caps. daily for 14 days.

In preparation for planned gynecological operations; in prenatal preparation of pregnant women at risk for bacterial vaginosis, 1 caps is used. morning and evening for 7 days or 1 caps. daily for 14 days - as part of complex therapy.

The dosage regimen should be adjusted depending on the severity of the clinical effect.

In order to prevent recurrence of vulvovaginal candidiasis (including exacerbations of recurrent vulvovaginal candidiasis), after local and / or systemic antifungal therapy, 1 caps is used. for the night. The duration of preparation therapy is determined by the doctor. The course of treatment should not exceed 21 days. The issue of conducting repeated courses is decided individually.

Side effect

Itching, burning, redness in the genital area, increased mucous discharge from the vagina.

Contraindications for use

Vulvovaginal candidiasis ("thrush").

Age up to 18 years (efficacy and safety not established).

Hypersensitivity to the components of the preparation.

Use during pregnancy and lactation

The preparation Lactogynal can be used during pregnancy and lactation (breastfeeding).

Use in children

Contraindicated in children under 18 years of age (efficacy and safety not established).

special instructions

After injection, the capsule dissolves without leaving stains on linen or odor. The preparation is intended for use in women over 18 years of age.

Overdose

Cases of overdose are not registered.

Preparation interaction

It is not recommended to use the preparation together with spermicidal agents. Perhaps simultaneous use with antibacterial, antiviral and immunomodulatory preparations. No clinically significant cases of interaction were registered.

0 reviews

There are no reviews for this product.